Showing results (501-510 of 1,188) with videos related to

Sort By:
Pageof 119
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Phase I study of bortezomib in refractory or relapsed acute leukemiasJorge Cortes, Deborah Thomas, Charles Koller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2026
Chromoanagenesis in Myelodysplastic Syndromes Is Associated With Highly Complex Karyotype, TP53 Disruption and Dismal PrognosisQing Wei, L Jeffrey Medeiros, Sanam Loghavi, et al.
BMJ Global Health|October 31, 2017
Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial GuineaHarparkash Kaur, Elizabeth Louise Allan, Ibrahim Mamadu, et al.
Blood|December 2, 2004
Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemiaAlfonso Quintas-Cardama, Hagop Kantarjian, Moshe Talpaz, et al.
Cancer|January 28, 2004
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapyGloria N Mattiuzzi, Hagop Kantarjian, Stefan Faderl, et al.
JAMA Network Open|October 4, 2021
Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income CountriesMarcello Tonelli, Sophanny Tiv, Shuchi Anand, et al.
Blood|December 9, 2008
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapyElias Jabbour, Hagop M Kantarjian, Dan Jones, et al.
Blood|November 19, 2011
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic valueMrinal M Patnaik, Terra L Lasho, Janice M Hodnefield, et al.
European Journal of Haematology|October 31, 2014
Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment responseQi Shen, Juan Ouyang, Guilin Tang, et al.
British Journal of Haematology|March 28, 2013
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITDKoichi Takahashi, Hagop Kantarjian, Naveen Pemmaraju, et al.
Pageof 119